Clinical trial / 1992
Dietary yeast intake was linked to higher disease activity in stable Crohn's disease.
Nineteen patients with stable Crohn's disease excluded dietary yeast for two months, receiving baker's yeast capsules during one month and placebo during the other. Mean Crohn's disease activity index was significantly higher when patients took baker's yeast (107.9) compared to yeast exclusion (102.1, p < 0.05). Maximum disease activity was also significantly lower during yeast exclusion (107.1) than during baseline (115.2) or yeast supplementation periods (113.9).
- Study type
- Clinical trial
- Who was studied
- 19 patients with stable chronic Crohn's disease
- What was measured
- Crohn's disease activity index
THE PAPER
The effect of dietary yeast on the activity of stable chronic Crohn's disease.
Barclay GR, McKenzie H, Pennington J, Parratt D, Pennington CR. Scand J Gastroenterol, 1992.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.